Collaboration is critical to making research progress. That’s why the SRF co-sponsored a recent workshop with the National Institutes of Health (NIH) & other nonprofit organizations to discuss scientific advances in immunotherapies and cellular therapies in systemic sclerosis (SSc) and chronic graft-versus-host disease (cGVHD).
Held on April 30 & May 1 at the NIH in Bethesda, Maryland, this workshop brought together more than 100 leaders and investigators in the fields of SSc and cGVHD for a day and a half of discussion and collaboration.
The meeting featured topical sessions with Q&A, including a panel that SRF Board Chairman Luke Evnin, PhD served on to share insights about “Novel Approaches to Funding and Infrastructure.“
This workshop created a unique opportunity to better understand mechanisms that contribute to both SSc and cGVHD, the biology of and therapeutic approaches to preventing and treating fibrosis, and to develop and foster collaborations across the fields. The Scleroderma Research Foundation was honored to be one of the co-sponsors of this important workshop, and we look forward to how these discussions will guide future efforts.
